Simon Farrell
SEC CIK 1965585 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics, Inc. | Chief Commercial Off | 81.2K | — | $549.1K | 4 | 2023-03-07 | 2025-03-10 |
Most active insiders at TRVI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Heffernan Michael Thomas | Dir | — | $595.8K |
| 2 | Galletta Christopher | See Remarks | — | — |
Simon Farrell made no open-market trades at TRVI in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-03-12 | 2025-03-10 | TRVI | Trevi Therapeutics, Inc. | Simon Farrell | Chief Commercial Off | S - Sale+OE | $6.75 | -81.3K | 81.2K | -50% | -$549.1K |
| DMT | 2025-03-12 | 2025-03-10 | TRVI | Trevi Therapeutics, Inc. | Simon Farrell | Chief Commercial Off | M - OptEx | $2.86 | +112.6K | 63.1K | New | +$321.6K |
| D | 2023-06-21 | 2023-06-20 | TRVI | Trevi Therapeutics, Inc. | Simon Farrell | Chief Commercial Off | M - OptEx | $0.51 | +6,250 | 45.6K | +16% | +$3,188 |
| D | 2023-03-08 | 2023-03-07 | TRVI | Trevi Therapeutics, Inc. | Simon Farrell | Chief Commercial Off | M - OptEx | $0.51 | +18.8K | 39.4K | +91% | +$9,562 |
Purchase Sale Sale after option exercise All abbreviations